John Gong is the founder of 3D Medicines. 3D Medicines has raised $140M in total funding. Backed by Efung Capital, China Capital Management, Adrian Cheng.
John Gong is the Chairman & CEO of 3D Medicines, a clinical-stage biopharmaceutical company focused on the development and commercialization of differentiated immuno-oncology drugs. He joined the company at a critical time when the biotech and pharmaceutical industries in China were rapidly expanding, driving the company's focus on oncology.
Full founder directory · Investor directory · Company funding database · Fundraising library